CH670084A5 - Prodn. of antiinflammatory 4-naphthyl-2-butanone deriv. - Google Patents
Prodn. of antiinflammatory 4-naphthyl-2-butanone deriv. Download PDFInfo
- Publication number
- CH670084A5 CH670084A5 CH53687A CH53687A CH670084A5 CH 670084 A5 CH670084 A5 CH 670084A5 CH 53687 A CH53687 A CH 53687A CH 53687 A CH53687 A CH 53687A CH 670084 A5 CH670084 A5 CH 670084A5
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- compound
- iii
- naphthyl
- reaction
- Prior art date
Links
- VEYCCHNUJNXSRR-UHFFFAOYSA-N 4-naphthalen-1-ylbutan-2-one Chemical compound C1=CC=C2C(CCC(=O)C)=CC=CC2=C1 VEYCCHNUJNXSRR-UHFFFAOYSA-N 0.000 title 1
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- BLXXJMDCKKHMKV-UHFFFAOYSA-N Nabumetone Chemical compound C1=C(CCC(C)=O)C=CC2=CC(OC)=CC=C21 BLXXJMDCKKHMKV-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000005903 acid hydrolysis reaction Methods 0.000 claims abstract description 6
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 4
- 150000001340 alkali metals Chemical class 0.000 claims abstract description 4
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 3
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 3
- 150000002367 halogens Chemical group 0.000 claims abstract description 3
- 150000001875 compounds Chemical class 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052744 lithium Inorganic materials 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- UJOQSHCJYVRZKJ-UHFFFAOYSA-N 3-(1,3-benzoxazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2OC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 UJOQSHCJYVRZKJ-UHFFFAOYSA-N 0.000 claims 1
- 102100024516 F-box only protein 5 Human genes 0.000 claims 1
- 101001052797 Homo sapiens F-box only protein 5 Proteins 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- -1 6-methoxy-2-naphthylmethyl halide Chemical class 0.000 abstract 1
- JIQXKYSNGXUDJU-UHFFFAOYSA-N propan-2-ylidenehydrazine Chemical compound CC(C)=NN JIQXKYSNGXUDJU-UHFFFAOYSA-N 0.000 abstract 1
- 150000007857 hydrazones Chemical class 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- RHUYHJGZWVXEHW-UHFFFAOYSA-N 1,1-Dimethyhydrazine Chemical compound CN(C)N RHUYHJGZWVXEHW-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 229960004270 nabumetone Drugs 0.000 description 2
- JYLGKVDVIPITQM-UHFFFAOYSA-N 2-(chloromethyl)-6-methoxynaphthalene Chemical compound C1=C(CCl)C=CC2=CC(OC)=CC=C21 JYLGKVDVIPITQM-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/72—Hydrazones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/516—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of nitrogen-containing compounds to >C = O groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868603778A GB8603778D0 (en) | 1986-02-15 | 1986-02-15 | Chemical process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH670084A5 true CH670084A5 (en) | 1989-05-12 |
Family
ID=10593134
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH53687A CH670084A5 (en) | 1986-02-15 | 1987-02-13 | Prodn. of antiinflammatory 4-naphthyl-2-butanone deriv. |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JPS62195344A (da) |
| CH (1) | CH670084A5 (da) |
| DK (1) | DK75487A (da) |
| ES (1) | ES2004879A6 (da) |
| GB (1) | GB8603778D0 (da) |
| GR (1) | GR870258B (da) |
| NL (1) | NL8700358A (da) |
| SE (1) | SE465926B (da) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0361067A1 (de) * | 1988-09-01 | 1990-04-04 | Bayer Ag | Disubstituierte Naphthaline, Verfahren zur Herstellung sowie deren herbizide Verwendung |
| EP2860169A3 (en) * | 2009-04-17 | 2015-10-21 | Centro De Neurociencias De Cuba | Method for obtaining novel derivatives of naphtalene for the in vivo diagnosis of Alzheimer's disease |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4943579A (en) * | 1987-10-06 | 1990-07-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble prodrugs of camptothecin |
| US5756851A (en) * | 1996-10-21 | 1998-05-26 | Albemarle Corporation | Production of nabumetone or precursors thereof |
-
1986
- 1986-02-15 GB GB868603778A patent/GB8603778D0/en active Pending
-
1987
- 1987-02-13 ES ES8700375A patent/ES2004879A6/es not_active Expired
- 1987-02-13 DK DK75487A patent/DK75487A/da unknown
- 1987-02-13 CH CH53687A patent/CH670084A5/de not_active IP Right Cessation
- 1987-02-13 GR GR870258A patent/GR870258B/el unknown
- 1987-02-13 NL NL8700358A patent/NL8700358A/nl not_active Application Discontinuation
- 1987-02-13 SE SE8700594A patent/SE465926B/sv unknown
- 1987-02-14 JP JP3229587A patent/JPS62195344A/ja active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0361067A1 (de) * | 1988-09-01 | 1990-04-04 | Bayer Ag | Disubstituierte Naphthaline, Verfahren zur Herstellung sowie deren herbizide Verwendung |
| US5108489A (en) * | 1988-09-01 | 1992-04-28 | Bayer Aktiengesellschaft | Herbicidal disubstituted naphthalenes |
| EP2860169A3 (en) * | 2009-04-17 | 2015-10-21 | Centro De Neurociencias De Cuba | Method for obtaining novel derivatives of naphtalene for the in vivo diagnosis of Alzheimer's disease |
Also Published As
| Publication number | Publication date |
|---|---|
| GB8603778D0 (en) | 1986-03-19 |
| SE8700594D0 (sv) | 1987-02-13 |
| NL8700358A (nl) | 1987-09-01 |
| DK75487A (da) | 1987-08-16 |
| SE465926B (sv) | 1991-11-18 |
| SE8700594L (sv) | 1987-08-16 |
| ES2004879A6 (es) | 1989-02-16 |
| JPS62195344A (ja) | 1987-08-28 |
| DK75487D0 (da) | 1987-02-13 |
| GR870258B (en) | 1987-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2726064C2 (de) | Verfahren zur Herstellung von 2-Phenyl-äthanol-Derivaten | |
| DE2240311B2 (de) | Verfahren zur Herstellung von ungesättigten cyvloaliphatischen Estern | |
| DE69717330T2 (de) | Verfahren zur Herstellung von 2-Chloro-5-Chloromethyl-1,3-Thiazol | |
| DE2424806A1 (de) | Antikoagulantien, verfahren zu ihrer herstellung und ihre verwendung | |
| CH670084A5 (en) | Prodn. of antiinflammatory 4-naphthyl-2-butanone deriv. | |
| DE1906401A1 (de) | Verfahren zur Herstellung von 4-Acyloxy-azetidin-2-onen | |
| DE2151492B2 (de) | Verfahren zur herstellung von p-menthadien-(1,8)-ol-(4) | |
| DE3316306C2 (de) | Verfahren zur Herstellung von alpha-substituierten, alpha,ß-ungesättigten Ketonen | |
| DE2820856C2 (da) | ||
| DE1301312B (de) | Verfahren zur Herstellung von Pyrryl-(2)-acetonitrilen | |
| DE2852975C2 (de) | 5-Cyano-1-alkylpyrrol-2-essigsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE3338853C2 (de) | Verfahren zur Herstellung von 2-Cyclopentenonen | |
| DE69211685T2 (de) | Bicyclo(4.1.0)heptan-2,4-dionderivat, zwischenprodukt zur synthese sowie verfahren zur herstellung | |
| EP0061669B1 (de) | Verbessertes Verfahren zur Herstellung von Cyclohexan-1,3-dionen sowie einige neue bicyclische Cyclohexan-1,3-dione | |
| DE2653601A1 (de) | Perfluoralkylgruppen enthaltende hydroxyketone | |
| DE2116159C3 (de) | Verfahren zur Herstellung von 4-Pyridylthio-essigsäure | |
| DE2440233C2 (de) | Verfahren zur Herstellung von 3,3'-Thiobis[2-methoxy-1-azabenzanthron] | |
| EP0081666A1 (de) | Verfahren zur Herstellung von Pentafluorbenzylalkohol | |
| EP0014478A1 (de) | Verfahren zur Herstellung von Alkyl-4,10-dihydro-10-oxo-thieno-(3,2-c)-(1)-benzoxepin-8-acetat | |
| DE3937282A1 (de) | Verfahren zur herstellung von alkyl-(3-chlorphenyl)-sulfonen | |
| DE1620564A1 (de) | Salze des Bis-(4-hydroxyphenyl)-(chinolyl-2)-methans und Verfahren zur Herstellung | |
| AT234698B (de) | Verfahren zur Herstellung von 4-Sulfanilamido-2,6-di-nieder-alkoxy-pyrimidinen | |
| DE3211663C2 (da) | ||
| DE2159655C3 (de) | Verfahren zur Herstellung von 2-(N-monosubstituierten Amino) -phenylketonen | |
| CH638487A5 (en) | Novel substituted di(phenylethyl)amines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |